Sangamo Therapeutics Schedules Q1 2026 Financial Results Release
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 11 2026
0mins
Source: Newsfilter
- Financial Results Announcement: Sangamo Therapeutics is set to release its Q1 2026 financial results after market close on May 14, 2026, reflecting the company's commitment to transparency and investor communication.
- Conference Call Details: The company will hold a conference call at 4:30 PM Eastern on the same day to discuss financial results and business updates, which is expected to attract significant attention from investors and analysts.
- Participation Registration Recommended: Participants are advised to register and join the call 10 minutes early, with options for both dial-in and dial-out connections provided to enhance engagement and interactivity during the call.
- Replay Availability: A replay of the financial results will be accessible on the company's website under the 'Investors and Media' section post-conference, further improving information accessibility and transparency for stakeholders.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
